glp-1 atrial fibrillation For patients with obesity and fibrillation, receptor agonist drugs may be the weight loss approach that better addresses their arrhythmia, observational data suggested. https://www.medpagetoday.com/cardiology/arrhythmias/120327 GLP‑1 Therapy Improves Atrial Fibrillation

, Deckert, V

By the time Knudsen returned from maternity leave in 1994, all of her former colleagues had left and the future of the GLP-1 project looked bleak

He noted that while the study was relatively short term, the effect was clear and said the once-daily pill could be particularly attractive as an option for people living with diabetes not wanting injectable therapy

The peptide agonist retains an -helical conformation as it sits deep within the receptor-binding pocket

The research was designed to build a broad picture of public attitudes towards weight loss treatment, including perceptions around injections, tablets, needles, convenience, effectiveness and confidence in using GLP-1 medications